Modulation of tumor-host interactions, angiogenesis, and tumor growth by tissue inhibitor of metalloproteinase 2 via a novel mechanism

Cancer Research
Andrew L FeldmanSteven K Libutti

Abstract

Solid tumors depend on angiogenesis for sustained growth. Tissue inhibitor of metalloproteinase 2 (TIMP-2) is an angiogenesis inhibitor initially characterized for its ability to block matrix metalloproteinases; however, recent data suggest that the antiangiogenic action of TIMP-2 may rely on matrix metalloproteinase-independent mechanisms. The aim of this study was to identify molecular pathways involved in the effects of TIMP-2 on processes dependent on tumor-host interactions such as angiogenesis. Using in vitro cell culture and a syngeneic murine tumor model, we compared the effects of TIMP-2 overexpression on gene expression profiles in vitro to those observed in vivo. Validating these findings by real-time quantitative PCR and layered protein scanning, we identified up-regulation of mitogen-activated protein kinase phosphatase 1 as an effector of the antiangiogenic function of TIMP-2. Up-regulation of mitogen-activated protein kinase phosphatase 1 in tumors overexpressing TIMP-2 leads to dephosphorylation of p38 mitogen-activated protein kinase and inhibition of tumor growth and angiogenesis. Phosphatase activity appears important in regulating tumor angiogenesis, offering a promising direction for the identification of n...Continue Reading

References

Jan 3, 1990·Journal of the National Cancer Institute·J Folkman
Nov 1, 1993·Journal of Cellular Physiology·A N MurphyW G Stetler-Stevenson
Aug 1, 1993·Journal of Cellular Physiology·H W SchnaperD L French
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C H CharlesN K Tonks
May 26, 1998·Seminars in Cell & Developmental Biology·S M Keyse
May 4, 1999·The Journal of Clinical Investigation·W G Stetler-Stevenson
May 18, 2001·Nature·L A Liotta, E C Kohn
Jul 5, 2001·Journal of the National Cancer Institute·A L FeldmanS K Libutti
Oct 26, 2002·BioTechniques·A L FeldmanS K Libutti
Jul 31, 2003·Cell·Dong-Wan SeoWilliam G Stetler-Stevenson

❮ Previous
Next ❯

Citations

Mar 23, 2005·Biochimie·Uta B HofmannJürgen C Becker
Dec 1, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sherry W YangSelvarangan Ponnazhagan
Sep 4, 2008·Reproductive Biology and Endocrinology : RB&E·Lena SahlinGunvor Ekman-Ordeberg
Jul 31, 2010·Journal of Oncology·N E CampbellJ Petrik
Jun 24, 2008·Critical Reviews in Clinical Laboratory Sciences·William Cruz-Munoz, Rama Khokha
Aug 26, 2011·The International Journal of Biochemistry & Cell Biology·Dorina BelottiGiulia Taraboletti
Sep 4, 2009·The Journal of Surgical Research·Huan N VuSteven K Libutti
Jul 25, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Katherine M FinanPaul N Reynolds
Dec 27, 2005·International Journal of Radiation Oncology, Biology, Physics·Mijung Kwon, Steven K Libutti
Feb 25, 2005·International Journal of Cancer. Journal International Du Cancer·Madeleine M Handsley, Dylan R Edwards
Jan 10, 2021·International Journal of Molecular Sciences·Griselda A Cabral-PachecoMargarita L Martinez-Fierro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.